Literature DB >> 20678990

In vitro and in vivo gene delivery mediated by Lactosylated dendrimer/alpha-cyclodextrin conjugates (G2) into hepatocytes.

Hidetoshi Arima1, Shogo Yamashita, Yoshimasa Mori, Yuya Hayashi, Keiichi Motoyama, Kenjiro Hattori, Tomoko Takeuchi, Hirofumi Jono, Yukio Ando, Fumitoshi Hirayama, Kaneto Uekama.   

Abstract

The purpose of this study is to evaluate in vitro and in vivo gene delivery efficiency of polyamidoamine (PAMAM) starburst dendrimer (generation 2, G2) conjugates with alpha-cyclodextrin (alpha-CDE (G2)) bearing lactose (Lac-alpha-CDE) with various degrees of substitution of the lactose moiety (DSL) as a novel hepatocyte-selective carrier in hepatocytes. Lac-alpha-CDE (DSL 2.6) was found to have much higher gene transfer activity than dendrimer, alpha-CDE, Lac-alpha-CDE (DSL 1.2, 4.6, 6.2 and 10.2) and lactosylated dendrimer (Lac-dendrimer, DSL 2.4) in HepG2 cells, which are dependent on the expression of cell-surface asialoglycoprotein receptor (ASGP-R), reflecting the cellular association of the plasmid DNA (pDNA) complexes. The physicochemical properties of pDNA complex with Lac-alpha-CDE (DSL 2.6) were almost comparable to that with alpha-CDE. Lac-alpha-CDE (DSL 2.6) provided negligible cytotoxicity up to a charge ratio of 150 in HepG2 cells. Lac-alpha-CDE (DSL 2.6) provided gene transfer activity higher than jetPEI-Hepatocyte to hepatocytes with much less changes of blood chemistry values 12h after intravenous administration in mice. These results suggest the potential use of Lac-alpha-CDE (DSL 2.6) as a non-viral vector for gene delivery toward hepatocytes. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20678990     DOI: 10.1016/j.jconrel.2010.05.030

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  12 in total

1.  A novel liver-targeted nitric oxide donor UDCA-Thr-NO protects against cirrhosis and portal hypertension.

Authors:  Jialin Sun; Menghua Li; Shiyong Fan; Zhongwu Guo; Bohua Zhong; Xueyuan Jin; Weiguo Shi
Journal:  Am J Transl Res       Date:  2018-02-15       Impact factor: 4.060

2.  Alterations of Hepatic Metabolism in Chronic Kidney Disease via D-box-binding Protein Aggravate the Renal Dysfunction.

Authors:  Kengo Hamamura; Naoya Matsunaga; Eriko Ikeda; Hideaki Kondo; Hisako Ikeyama; Kazutaka Tokushige; Kazufumi Itcho; Yoko Furuichi; Yuya Yoshida; Masaki Matsuda; Kaori Yasuda; Atsushi Doi; Yoshifumi Yokota; Toshiaki Amamoto; Hironori Aramaki; Yasuhiro Irino; Satoru Koyanagi; Shigehiro Ohdo
Journal:  J Biol Chem       Date:  2016-01-04       Impact factor: 5.157

Review 3.  Molecular-genetic imaging of cancer.

Authors:  Il Minn; Mitchell E Menezes; Siddik Sarkar; Keerthi Yarlagadda; Swadesh K Das; Luni Emdad; Devanand Sarkar; Paul B Fisher; Martin G Pomper
Journal:  Adv Cancer Res       Date:  2014       Impact factor: 6.242

4.  In vitro investigations of the efficacy of cyclodextrin-siRNA complexes modified with lipid-PEG-Octaarginine: towards a formulation strategy for non-viral neuronal siRNA delivery.

Authors:  Aoife M O'Mahony; Stephane Desgranges; Julien Ogier; Aoife Quinlan; Marc Devocelle; Raphael Darcy; John F Cryan; Caitriona M O'Driscoll
Journal:  Pharm Res       Date:  2012-11-29       Impact factor: 4.200

5.  In vivo fate tracking of degradable nanoparticles for lung gene transfer using PET and Ĉerenkov imaging.

Authors:  Kvar C L Black; Aida Ibricevic; Sean P Gunsten; Jeniree A Flores; Tiffany P Gustafson; Jeffery E Raymond; Sandani Samarajeewa; Ritu Shrestha; Simcha E Felder; Tianyi Cai; Yuefei Shen; Ann-Kathrin Löbs; Natalia Zhegalova; Deborah H Sultan; Mikhail Berezin; Karen L Wooley; Yongjian Liu; Steven L Brody
Journal:  Biomaterials       Date:  2016-05-03       Impact factor: 15.304

6.  In Vitro Gene Delivery Mediated by Asialofetuin-Appended Cationic Liposomes Associated with γ-Cyclodextrin into Hepatocytes.

Authors:  Keiichi Motoyama; Yoshihiro Nakashima; Yukihiko Aramaki; Fumitoshi Hirayama; Kaneto Uekama; Hidetoshi Arima
Journal:  J Drug Deliv       Date:  2010-12-09

Review 7.  Current progress in gene delivery technology based on chemical methods and nano-carriers.

Authors:  Lian Jin; Xin Zeng; Ming Liu; Yan Deng; Nongyue He
Journal:  Theranostics       Date:  2014-01-15       Impact factor: 11.556

Review 8.  Twenty Years of Research on Cyclodextrin Conjugates with PAMAM Dendrimers.

Authors:  Hidetoshi Arima
Journal:  Pharmaceutics       Date:  2021-05-11       Impact factor: 6.321

9.  Potential Use of Polyamidoamine Dendrimer Conjugates with Cyclodextrins as Novel Carriers for siRNA.

Authors:  Hidetoshi Arima; Keiichi Motoyama; Taishi Higashi
Journal:  Pharmaceuticals (Basel)       Date:  2011-12-30

10.  Polyamidoamine Dendrimer Conjugates with Cyclodextrins as Novel Carriers for DNA, shRNA and siRNA.

Authors:  Hidetoshi Arima; Keiichi Motoyama; Taishi Higashi
Journal:  Pharmaceutics       Date:  2012-02-01       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.